Trial Site Detail

 

Drug:	Dovitinib
Trial:	Dovitinib for Patients With Tumor Pathway Activations Inhibited by Dovitinib
Conditions:	Gastrointestinal Stromal Tumor
Trial Status:	Completed

 

Comprehensive Cancer Centers of Nevada 3730 S. Eastern Avenue      Las Vegas , NV 89169 USA

 

Principal Investigator:
Contact:
Activation Status of this Site:	Closed
Notes about this Site:
Comprehensive Cancer Centers of Nevada Website:	http://www.cccnevada.com/clinical-research/active-trials/

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.